Kuros Biosciences AG (KURN):製品パイプライン分析

GlobalDataが発行した調査報告書(GDME81908PD)
◆英語タイトル:Kuros Biosciences AG (KURN) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME81908PD
◆発行会社(リサーチ会社):GlobalData
◆発行日:2021年1月
◆ページ数:32
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:Switzerland
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Kuros Biosciences AG (Kuros Biosciences) is a developer of products for tissue repair and regeneration. It develops a family of bone healing products to address indications in trauma and spine called orthobiologics. It is focused on bone repair for trauma, specifically fracture repair, as well as on spinal fusion. Its pipeline of products are being developed for spinal fusion, fracture repair and as surgical sealants. Kuros Biosciences uses a synthetic matrix technology with reliable and pressure resistant, rapid closure of the damaged tissues. The company’s lead sealant product is Neuroseal. The company operates in Schlieren, Switzerland; Bilthoven, the Netherlands; Burlington, USA and in Konstanz, Germany. Kuros Biosciences is headquartered in Schlieren, Switzerland.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Kuros Biosciences AG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Kuros Biosciences AG Company Overview
Kuros Biosciences AG Company Snapshot
Kuros Biosciences AG Pipeline Products and Ongoing Clinical Trials Overview
Kuros Biosciences AG – Pipeline Analysis Overview
Business Description
Kuros Biosciences AG – Key Facts
Kuros Biosciences AG – Major Products and Services
Kuros Biosciences AG Pipeline Products by Development Stage
Kuros Biosciences AG Pipeline Products Overview
KUR – 111
KUR – 111 Product Overview
KUR – 211
KUR – 211 Product Overview
KUR – 212
KUR – 212 Product Overview
KUR-112
KUR-112 Product Overview
KUR-113 – Fracture Repair
KUR-113 – Fracture Repair Product Overview
KUR-113 – Spinal Fusion
KUR-113 – Spinal Fusion Product Overview
Neuroseal – Cranial
Neuroseal – Cranial Product Overview
Kuros Biosciences AG – Key Competitors
Kuros Biosciences AG – Key Employees
Kuros Biosciences AG – Key Employee Biographies
Kuros Biosciences AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Kuros Biosciences AG, Recent Developments
Dec 03, 2019: Kuros announces final result of Capital Increase – total gross proceeds of CHF 12.5 million raised
Oct 02, 2019: Kuros Biosciences to host key opinion leader meeting in Zurich showcasing its commercial stage advanced Bone Graft MagnetOs
Sep 24, 2019: Kuros Biosciences announces full commercial launch of MagnetOs and exhibitor status at North American Spine Society 34 th Annual Meeting
Aug 20, 2019: Kuros Biosciences reports results for first half 2019
Jul 24, 2019: Kuros announces Gerhard Ries is stepping down as Board member
Jul 09, 2019: Kuros Biosciences signs agreement with Surgical Specialties on distribution of MagnetOs in Australia and New Zealand
Apr 30, 2019: Kuros Biosciences to propose re-appointment of chairman and board members at Annual General Meeting
Apr 12, 2019: Kuros Biosciences reports results for the full year 2018
Mar 13, 2019: Kuros Biosciences receives US marketing clearance for intervertebral body fusion device
Dec 17, 2018: Kuros ends transformational year with first MagnetOs sales, lead clinical program on track
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Kuros Biosciences AG Pipeline Products and Ongoing Clinical Trials Overview
Kuros Biosciences AG Pipeline Products by Equipment Type
Kuros Biosciences AG Pipeline Products by Indication
Kuros Biosciences AG, Key Facts
Kuros Biosciences AG, Major Products and Services
Kuros Biosciences AG Number of Pipeline Products by Development Stage
Kuros Biosciences AG Pipeline Products Summary by Development Stage
KUR - 111 - Product Status
KUR - 111 - Product Description
KUR - 211 - Product Status
KUR - 211 - Product Description
KUR - 212 - Product Status
KUR - 212 - Product Description
KUR-112 - Product Status
KUR-112 - Product Description
KUR-113 - Fracture Repair - Product Status
KUR-113 - Fracture Repair - Product Description
KUR-113 - Spinal Fusion - Product Status
KUR-113 - Spinal Fusion - Product Description
Neuroseal - Cranial - Product Status
Neuroseal - Cranial - Product Description
Kuros Biosciences AG, Key Employees
Kuros Biosciences AG, Key Employee Biographies
Kuros Biosciences AG, Subsidiaries
Glossary

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Kuros Biosciences AG (KURN):製品パイプライン分析(Kuros Biosciences AG (KURN) - Product Pipeline Analysis, 2020 Update)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆